You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Joint TGA and Medsafe project: Trans-Tasman early warning system of safety concerns with medicines and medical devices
This consultation closed on 7 April 2013
*Large file warning: Attempting to open large pdf files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
The consultation document is titled: The Trans-Tasman early warning system: How the process will work in Australia and New Zealand. This document contains a description of the proposed process for the early warning system for Australia and New Zealand and includes example web pages.
- Consultation: The Trans-Tasman early warning system: How the process will work in Australia and New Zealand (pdf,597kb)
- Consultation: The Trans-Tasman early warning system: How the process will work in Australia and New Zealand (Microsoft Word,711kb)
The TGA sought comments and input from interested parties on the proposed process and example web pages for an early warning system for medicines and medical devices. Medsafe is running a parallel consultation. This scheme will operate in parallel in Australia and New Zealand. Comments will be used to inform the process for both countries.
Document released for consultation on 8 March 2013.
Interested parties should respond by close of business 7 April 2013.
Feedback will be released following consideration of submissions (see 'What will happen').
- This discussion/information paper outlines a description of the proposed process for a parallel early warning system for safety concerns with medicines and medical devices in Australia and New Zealand.
- Example web pages including hypothetical safety communications are included in the consultation.
Through the consultation process, the TGA and Medsafe are seeking comments from interested parties on the:
- proposed webpages
- presentation of the hypothetical examples
- proposed communication channels.
Submissions may address any, or all, of the following areas:
- the proposed webpages
- the presentation of the hypothetical examples
- the proposed communication channels.
In addition, submissions may include general comments on the proposed scheme.
Submissions will be reviewed by the TGA and Medsafe and feedback on submissions will be provided through the TGA and Medsafe websites. Input on the early warning system will be used to help inform the Australian and New Zealand governments on implementation of this system.
All Australian submissions will be placed on the TGA website unless marked confidential. Any confidential material contained within your submission should be clearly marked 'IN CONFIDENCE'. Reasons for a claim to confidentiality must be included in the space provided on the submission coversheet.
For submissions made by individuals, all personal details other than your name will be removed from your submission before it is published on the TGA website.
In addition, a list of parties making submissions will be published. If you do not wish to be identified with your submission you must specifically request this in the space provided on the submission coversheet.
Any questions relating to submissions should be directed to the TGA by email to firstname.lastname@example.org.